JAN 04, 2020 11:44 AM PST

Testing Gene Therapy as a Potential Treatment for CTE

WRITTEN BY: Carmen Leitch

Repeated trauma to the head, like a boxer, football player, or soldier might experience, appears to cause a degenerative disease called chronic traumatic encephalopathy (CTE). Researchers are still learning about the disease, and physical evidence connecting repeated head trauma to a disorder was discovered only recently, in 2002 by Dr. Bennet Omalu.

There is no specific symptom that has been conclusively linked to CTE, which can only be diagnosed by a post-mortem examination of the brain. But, symptoms may include problems thinking or carrying out tasks, depression, apathy, impulsive behavior, short-term memory loss, emotional instability, substance abuse, or suicidal thoughts.

Little is known about how the disease progresses or how to treat it. However, a protein called tau is known to build up in the brains of people with CTE, after they become chemically altered in a way that's called hyperphosphorylation. Tau proteins form in a pattern that's specific to CTE, and has also been detected at abnormally high levels in a study of people that had experienced repeated head trauma. That work suggested that high Tau levels may be a biomarker for the disease.

 New research reported in Human Gene Therapy has investigated whether gene therapy might be an effective therapeutic for CTE. Researchers delivered a viral vector (the typical carrier for gene therapy) directly to the brains of a mouse model of CTE. The scientists found that this approach significantly reduced the levels of a hyperphosphorylated form of Tau protein, called pTau.

"CTE is much more prevalent than was initially realized, and there is currently no therapy available," said Human Gene Therapy's Editor-in-Chief Terence R. Flotte, M.D., Celia and Isaac Haidak Professor of Medical Education and Dean, Provost. "This new work from the Crystal laboratory is potentially ground-breaking as a means to remove the offending Tau phoshoprotein."


Sources: AAAS/Eurekalert! via Mary Ann Liebert, Inc./Genetic Engineering News, Human Gene Therapy

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 14, 2020
Clinical & Molecular DX
Cell Line Authentication Using STR Analysis
SEP 14, 2020
Cell Line Authentication Using STR Analysis
Imagine you’re studying colon cancer using a colon cell line model. After three painstaking years of research, you ...
SEP 11, 2020
Genetics & Genomics
A Better Understanding of Telomere Length Throughout the Body
SEP 11, 2020
A Better Understanding of Telomere Length Throughout the Body
Telomeres cap the ends of chromosomes. They work to protect the chromosomes from degradation, and are known to get short ...
SEP 13, 2020
Genetics & Genomics
Men and Women Express Many Genes at Different Levels
SEP 13, 2020
Men and Women Express Many Genes at Different Levels
Most humans carry the same genes in their genome, but how are genes expressed differently in men and women?
NOV 12, 2020
Cardiology
Creating a Mouse Model to Test RBM20 Dependent Dilated Cardiomyopathy
NOV 12, 2020
Creating a Mouse Model to Test RBM20 Dependent Dilated Cardiomyopathy
Cardiovascular disease is something that, in most cases, is within our ability to control. A healthy diet and active lif ...
NOV 15, 2020
Genetics & Genomics
Novel Cancer-Driving Genes are Discovered
NOV 15, 2020
Novel Cancer-Driving Genes are Discovered
Cells have to be able to divide so new ones can replenish cells that get worn out, dysfunctional, or that accumulate dam ...
NOV 27, 2020
Cell & Molecular Biology
UVC Rays May be a Bigger Cancer Risk Than Known
NOV 27, 2020
UVC Rays May be a Bigger Cancer Risk Than Known
The sun emits different kinds of light and rays including visible and ultraviolet (UV) and infrared. Some of those forms ...
Loading Comments...